Development
Evaxion Biotech A/S
EVAX
$3.13
$0.5521.32%
NASDAQ
| 09/30/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | ||
|---|---|---|---|---|---|
| Net Income | -5.68M | -- | -- | -5.74M | |
| Total Depreciation and Amortization | 200.00K | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 781.00K | -- | -- | -328.00K | |
| Change in Net Operating Assets | 307.00K | -- | -- | -501.00K | |
| Cash from Operations | -4.39M | -- | -- | -6.57M | |
| Capital Expenditure | -65.00K | -- | -- | -89.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 0.00 | -- | -- | 1.00K | |
| Cash from Investing | -65.00K | -- | -- | -88.00K | |
| Total Debt Issued | 65.00K | -- | -- | 84.00K | |
| Total Debt Repaid | -119.00K | -- | -- | -101.00K | |
| Issuance of Common Stock | 154.00K | -- | -- | 20.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -4.00K | -- | -- | -134.00K | |
| Cash from Financing | 96.00K | -- | -- | -131.00K | |
| Foreign Exchange rate Adjustments | -154.00K | -- | -- | -613.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -4.51M | -- | -- | -7.40M | |